Abstract
Management of craniopharyngiomas is still controversial. 28 children with this tumor were studied. GH deficiency was present in 22 patients following surgery, 10 of these GH-lacking patients had normal or accelerated growth (usually associated with rapid weight gain) postoperatively. Somatomedin levels were normal in three of six normally growing patients. After craniotomy their basal and TRH-stimulated prolactin levels were in the normal range, but their insulin secretion was markedly increased. Postoperatively there was a significant correlation between peak insulin levels following arginine infusion and growth velocity in all patients.
Complete tumor removal could be performed in 28% of our patients. Altogether 36% of all patients had at least one tumor recurrence. Recent literature with the addition of our series showed tumor recurrence in 22% of patients with “total” tumor excision and in 72% of patients with partial tumor removal. Radiotherapy seems to be capable of destroying craniopharyngioma tissue. The recurrence rate was only 26% in patients with subtotal excision plus radiotherapy. Unless radical tumor removal can be attempted with safety, subtotal tumor removal plus radiotherapy appears to be the treatment of choice for craniopharyngioma.
Similar content being viewed by others
Abbreviations
- SD:
-
Standard Deviation
- SDS:
-
Standard Deviation Score
- SEM:
-
Standard Error of the Mean
- BA:
-
Bone Age
- CA:
-
chronological Age
- RIA:
-
Radioimmunoassay
- GH:
-
Growth Hormone
- TRH:
-
Thyrotropin Releasing Hormone
References
Ahlskog JE, Hoebel BG (1973) Overeating and obesity from damage to a noradrenergic system in the brain. Science 182: 166–169
Amacher AL (1980) Craniopharyngioma: The controversy regarding radiotherapy. Child's brain 6:57–64
Azar-Kia B, Krishnan UR, Schechter MM (1975) Neonatal craniopharyngioma. J Neurosurg 42:91–93
Bamford FN, Jones PM, Pearson D, Ribeiro GG, Shalet SM, Beardwell CG (1976) Residual disabilities in children treated for intracranial space-occupying lesions. Cancer 37:1149–1151
Banna M (1976) Craniopharyngioma: Based on 160 cases. Br J Radiol 49:206–223
Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83:781–785
Bartlett JR (1971) Craniopharyngiomas—a summary of 85 cases. J Neurol Neurosurg Psychiatry 34:37–41
Beck JC, Gonda A, Hamid MA, Morgen RO, Rubinstein D, McGarry EE (1964) Some metabolic changes induced by primate growth hormone and purified ovine prolactin. Metabolism 13:1108–1134
Bloom HJG (1975) Combined modality therapy for intracranial tumors. Cancer 35:111–120
Bray GA (1979) Nutritional factors in disease. In: Sodeman WA, Sodeman TM (eds) Pathologic Physiology. WB Saunders, London Philadelphia Toronto, pp 971–976
Carpenter RC, Chamberlin GW, Frazier CH (1937) The treatment of hypophyseal stalk tumors by evacuation and irradiation. Am J Roentgenol 38:162–177
Costin G, Kogut MD, Phillipps LS, Daughaday WH (1976) Craniopharyngioma: The role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 42:370–379
Daughaday WH, Phillipps LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214–1219
Eiser C (1978) Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child 53:391–395
Finkelstein JW, Kream J, Ludan A, Hellman L (1972) Sulfation factor (somatomedin): An explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors. J Clin Endocrinol Metab 35:13–17
Francis MJO, Hill DJ (1975) Prolactin-stimulated production of somatomedin by rat liver. Nature 255:167–168
Frasier SD, Smith FG (1968) Return of normal growth following removal of a craniopharyngioma. Am J Dis Child 116:311–314
Frohman LA, Bernardis LL (1968) Growth hormone and insulin levels in weanling rats with ventromedial hypothalamic lesions. Endocrinology 82:1125–1132
Girard J (1981) Intracranial space-occupying lesions. In: Brook CGD (ed) Clinical Paediatric Endocrinology. Blackwell Scientific, Oxford London, pp 275–284
Gluckman PD, Holdaway IM (1976) Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth. Clin Endocrinol 5:545–549
Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Oxford University, London
Harris JR, Levene MB (1976) Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120:167–171
Hill DJ, Francis MJO, Milner RDG (1977) Action of rat prolactin on plasma somatomedin levels in the rat and on somatomedin release from perfused rat liver. J Endocrinol 75:137–143
Hoff JT, Patterson RH (1972) Craniopharyngiomas in children and adults. J Neurosurg 36:299–302
Hoffman HJ, Hendrick EB, Humphreys RP, Buncic JR, Armstrong DL, Jenkin RDT (1977) Management of craniopharyngioma in children. J Neurosurg 47:218–227
Holder AT, Preece MA (1981) The somatomedins. In: Brook CGD (ed) Clinical Paediatric Endocrinology. Blackwell Scientific, Oxford London, pp 96–112
Holder AT, Wallis M, Biggs P, Preece MA (1980) Effects of growth hormone, prolactin and thyroxine on body weight, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice. J Endocrinol 85:35–47
Holmes LB, Frantz AG, Rabkin MT, Soeldner JS, Crawford JD (1968) Normal growth with subnormal growth hormone levels. N Engl J Med 279:559–566
Inoue S, Bray GA, Mullen YS (1978) Transplantation of pancreatic β-cells prevents development of hypothalamic obesity in rat. Am J Physiol 235:E 266-E 271
Iyer CGS (1952) Case report of an adamantinoma present at birth. J Neurosurg 9:221–228
Jenkins JS, Gilbert CJ, Ang V (1976) Hypothalamic-pituitary function in patients with craniopharyngiomas. J Clin Endocrinol Metab 43:394–399
Kahn EA, Gosch HH, Seeger JF, Hicks SP (1973) Forty-five years experience with the craniopharyngiomas. Surg Neurol 1:5–12
Katz EL (1975) Late results of radical excision of craniopharyngiomas in children. J Neurosurg 42:86–90
Kennedy HB, Smith RJS (1975) Eye signs in craniopharyngioma. Br J Ophthalmol 59:689–695
Kenny FM, Guyda HJ, Wright JC, Friesen HG (1973) Prolactin and somatomedin in hypopituitary patients with “Catch-up” growth following operations for craniopharyngioma. J Clin Endocrinol Metab 36:378–380
Kramer S, Southard M, Mansfield CM (1968) Radiotherapy in the management of craniopharyngiomas. Am J Roentgenol 103:44–52
Leddy ET, Marshall TM (1951) Roentgen therapy of pituitary adamantinomas (craniopharyngiomas). Radiology 56:384–393
Lichter AS, Wara WM, Sheline GE, Townsend JJ, Wilson CB (1977) The treatment of craniopharyngiomas. Int J Radiat Oncol Biol Phys 2:675–683
Martin JM, Konijnendijk W, Bouman PR (1974) Insulin and growth hormone secretion in rats with ventromedial hypothalamic lesions maintained on restricted food intake. Diabetes 23:203–208
Martins AN, Johnston JS, Henry JM, Stoffel TJ, DiChiro G (1977) Delayed radiation necrosis of the brain. J Neurosurg 47:336–345
Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10: 116–129
Matson DD, Crigler JF (1969) Management of craniopharyngioma in childhood. J Neurosurg 30:377–390
McKissock W, Ford RK (1966) Results of treatment of the craniopharyngiomas. J Neurol Neurosurg Psychiatry 29:475
McMurry FG, Hardy RW, Dohn DF, Sadar E, Gardner WJ (1977) Long term results in the management of craniopharyngiomas. Neurosurgery 1:238–241
Mori K, Takeuchi J, Ishikawa M, Handa H, Toyama M, Yamaki T (1978) Occlusive arteriopathy and brain tumor. J Neurosurg 49:22–35
Mori K, Handa H, Murata T, Takeuchi J, Miwa S, Osaka K (1980) Results of treatment for craniopharyngioma. Child's brain 6: 303–312
Onoyama J, Ono K, Yabumoto E, Takeuchi J (1977) Radiation therapy of craniopharyngioma. Radiology 125:799–803
Petito CK, DeGirolami U, Earle KM (1976) Craniopharyngiomas. Cancer 37:1944–1952
Phillips LS (1979) Nutritional regulation of somatomedin activity and growth. In: Giordano G, van Wyk JJ, Minuto F (eds) Somatomedins and growth. Academic Press, London NewNork, pp 311–323
Shapiro K, Till K, Grant N (1979) Craniopharyngiomas in childhood. J Neurosurg 50:617–623
Sharma U, Tandon PN, Saxena KK, Singhal RM, Baruah JD (1974) Craniopharyngiomas treated by a combination of surgery and radiotherapy. Clin Radiol 25:13–17
Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1:1330–1331
Sogg RL, Donaldson SS, Yorke CH (1978) Malignant astrocytoma following radiotherapy of a craniopharyngioma. J Neurosurg 48:622–627
Stahnke N, Schönberg D, Steins P, Willig RP, Blunck W (1975) Subnormal growth hormone (GH) levels with normal growth. Pediatr Res 9:674
Stahnke N, Blunck W (1979) Insulinsekretion bei 3 Gruppen von Patienten mit STH-Mangel. Klin Wochenschr 57:361
Stahnke N, Willig RP (1981) Endokrine Diagnostik von hypothalamisch-hypophysären Störungen im Kindesalter. Monatsschr Kinderheilkd 129:81–90
Stahnke N, Ilicki A, Willig RP (1979) Effects of cyproterone acetate (CA) on growth and endocrine function in precocious puberty. Acta Paediatr Scand [Suppl] 277:32–40
Svolos DG (1969) Craniopharyngiomas. Acta Chir Scand [Suppl] 403:1–44
Sweet WH (1976) Radical surgical treatment of craniopharyngioma. Clin Neurosurg 23:52–79
Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: Britisch Children, 1965. Arch Dis Child 41:454–471; 613–635
Tanner JM, Whitehouse RH, Hughes PCR, Vince FP (1971) Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight inherited smallness. Turner's syndrome, and other complaints. Arch Dis Child 46:745–782
Thompson IL, Griffin TW, Parker RG, Blasko JC (1978) Craniopharyngioma: The role of radiation therapy. Int J Radiat Oncol Biol Phys 4:1059–1063
Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients. J Pediatr 97:728–735
Urdaneta N, Chessin H, Fischer JJ (1976) Pituitary adenomas and craniopharyngiomas: analysis of 99 cases treated with radiation therapy. Int J Radiat Oncol Biol Phys 1:895–902
Van den Brande JL, van Buul-Offers SC, DuCaju MVL, Price DA, Wit JM, Bongers-Schokking JJ (1979) Somatomedin and the regulation of statural growth. In: Giordano G, van Wyk JJ, Minuto F (eds) Somatomedins and growth. Academic Press, London New York, pp 255–261
Van der Schueren-Lodeweyckx M (1981) Endocrinology of growth. In: Brook CGD (ed) Clinical paediatric Endocrinology. Blackwell Scientific. Oxford London, pp 73–95
Van Wyk JJ, Underwood LE, Lister RC, Marshall RN (1973) The somatomedins. A new class of growth-regulating hormones? Am J Dis Child 126:705–711
Waga S, Handa H (1976) Radiation-induced meningioma: With review of literature. Surg Neurol 5:215–219
Weldon V (1972) In: Daughaday WH, Garland JT: The sulfation factor hypothesis: recent observations. In: Pecile A, Müller EE (eds) Growth and growth hormone. Excerpta Medica, International Congress Series No 244, Amsterdam
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stahnke, N., Grubel, G., Lagenstein, I. et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 142, 179–185 (1984). https://doi.org/10.1007/BF00442445
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00442445